Cargando…
Signaling Molecules Regulating Pancreatic Endocrine Development from Pluripotent Stem Cell Differentiation
Diabetes is one of the leading causes of death globally. Currently, the donor pancreas is the only source of human islets, placing extreme constraints on supply. Hence, it is imperative to develop renewable islets for diabetes research and treatment. To date, extensive efforts have been made to deri...
Autores principales: | Huang, Hui, Bader, Taylor N., Jin, Sha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461594/ https://www.ncbi.nlm.nih.gov/pubmed/32824212 http://dx.doi.org/10.3390/ijms21165867 |
Ejemplares similares
-
Inhibition of activin/nodal signalling is necessary for pancreatic differentiation of human pluripotent stem cells
por: Cho, C. H.-H., et al.
Publicado: (2012) -
Enhanced differentiation of human pluripotent stem cells into pancreatic endocrine cells in 3D culture by inhibition of focal adhesion kinase
por: Liu, Xiaofang, et al.
Publicado: (2020) -
Generation of pancreatic progenitors from human pluripotent stem cells by small molecules
por: Jiang, Yuqian, et al.
Publicado: (2021) -
Transcriptome-Powered Pluripotent Stem Cell Differentiation for Regenerative Medicine
por: Ogi, Derek A., et al.
Publicado: (2023) -
Signaling Molecules Governing Pluripotency and Early Lineage
Commitments in Human Pluripotent Stem Cells
por: Fathi, Ali, et al.
Publicado: (2017)